Vaccination in Bangladesh includes all aspects of vaccination in Bangladesh.
A 2020 study reported that the cost of a malaria vaccination program in Bangladesh would be cost effective in terms of increasing the people's disability-adjusted life years.[1]
Bangladesh had its first outbreak of avian influenza in 2007 and the disease continues to be a national problem.[2] Part of the response that scientists recommend is the development of vaccination programs, but this has been difficult.[3]
A 2016 program to provide HPV vaccines to girls created a range of ethical issues for communities.[4] The source of all the problems was that the design of the vaccination program came from foreign people outside the country who had no understanding of local cultural norms.[4] There was an attempt at local consultation, but unexpected problems happened anyway.[4] Problems included lack of public health education for the communities receiving the vaccine, forcefulness and lack of consent in arranging for girls to take the vaccine, a lack of planning to treat adverse side effects of vaccination, and a lack of female leadership and empowerment in running a health program for females.[4]
There are multiple cholera vaccines available in Bangladesh as well as multiple strategies for making them available to people who need them.[5] While there is major government support for vaccination, there is debate and research about how to manage the vaccination program to make it more efficient.[5]
Bangladesh has experienced outbreaks of the Nipah virus and although a vaccine exists, the vaccine option is not well developed and preventing outbreaks without vaccines is a better option in this case.[6]
Bangladesh began a vaccination program for congenital rubella syndrome in 2012 and since then, cases have gone down greatly.[7]
COVID-19 vaccination edit
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.[8][9]
References edit
- ^ Sarker, AR; Sultana, M (2020). "Cost-effective analysis of childhood malaria vaccination in endemic hotspots of Bangladesh". PLOS ONE. 15 (5): e0233902. Bibcode:2020PLoSO..1533902S. doi:10.1371/journal.pone.0233902. PMC 7259743. PMID 32470101.
- ^ Rimi, NA; Hassan, MZ; Chowdhury, S; Rahman, M; Sultana, R; Biswas, PK; Debnath, NC; Islam, SS; Ross, AG (11 September 2019). "A Decade of Avian Influenza in Bangladesh: Where Are We Now?". Tropical Medicine and Infectious Disease. 4 (3): 119. doi:10.3390/tropicalmed4030119. PMC 6789720. PMID 31514405.
- ^ Parvin, R; Nooruzzaman, M; Kabiraj, CK; Begum, JA; Chowdhury, EH; Islam, MR; Harder, T (12 July 2020). "Controlling Avian Influenza Virus in Bangladesh: Challenges and Recommendations". Viruses. 12 (7): 751. doi:10.3390/v12070751. PMC 7412482. PMID 32664683.
- ^ a b c d Salwa, M; Abdullah Al-Munim, T (15 June 2018). "Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh". BMC Medical Ethics. 19 (Suppl 1): 39. doi:10.1186/s12910-018-0287-0. PMC 6019993. PMID 29945621.
- ^ a b Islam, MT; Chowdhury, F; Qadri, F; Sur, D; Ganguly, NK (29 February 2020). "Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward". Vaccine. 38: A127–A131. doi:10.1016/j.vaccine.2019.06.082. PMID 31301917. S2CID 196617648.
- ^ Ochani, RK; Batra, S; Shaikh, A; Asad, A (1 June 2019). "Nipah virus – the rising epidemic: a review". Le Infezioni in Medicina. 27 (2): 117–127. PMID 31205033.
- ^ Chan, J; Wu, Y; Wood, J; Muhit, M; Mahmood, MK; Karim, T; Moushumi, F; Jones, CA; Snelling, T; Khandaker, G (2020). "Burden of Congenital Rubella Syndrome (CRS) in Bangladesh: Systematic Review of Existing Literature and Transmission Modelling of Seroprevalence Studies". Infectious Disorders Drug Targets. 20 (3): 284–290. doi:10.2174/1871526518666181004092758. PMID 30289078. S2CID 52921583.
- ^ "Bangladesh starts COVID vaccination drive use". Al Jazeera. 28 January 2021. Retrieved 30 April 2021.
- ^ "Bangladesh starts nationwide COVID vaccination drive use". Anadolu Agency. 7 February 2021. Retrieved 30 April 2021.